A-381393


CAS No. : 726174-00-1

A-381393,726174-00-1
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000245
Synonyms:A-381393;2-[[4-(3,4-dimethylphenyl)piperazin-1-yl]methyl]-1H-benzimidazole
Molecular Formula:C20H24N4
Molecular Weight:320.44
Target:dopamine D4 antagonist
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

refresh
Appearance:Solid powder
Purity: > 98%
Cat No:I000245
Cas No:726174-00-1
Product-Name:A-381393
InChI:InChI=1S/C20H24N4/c1-15-7-8-17(13-16(15)2)24-11-9-23(10-12-24)14-20-21-18-5-3-4-6-19(18)22-20/h3-8,13H,9-12,14H2,1-2H3,(H,21,22)
InChIKey:SAQMCVDGOIRQTC-UHFFFAOYSA-N
SMILES:CC1=CC=C(N2CCN(CC3=NC4=CC=CC=C4N3)CC2)C=C1C
A-381393 is a potent and selective agonist of the dopamine D4 receptor.
1:Neuropharmacology. 2005 Jul;49(1):112-21. Epub 2005 Apr 1. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.Nakane M,Cowart MD,Hsieh GC,Miller L,Uchic ME,Chang R,Terranova MA,Donnelly-Roberts DL,Namovic MT,Miller TR,Wetter JM,Marsh K,Stewart AO,Brioni JD,Moreland RB, PMID: 15992586 DOI: 10.1016/j.neuropharm.2005.02.004
Abstract: 2-[4-(3,4-Dimethylphenlyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393) was identified as a potent dopamine D4 receptor antagonist with excellent receptor selectivity. [3H]-spiperone competition binding assays showed that A-381393 potently bound to membrane from cells expressing recombinant human dopamine D4.4 receptor (Ki=1.5 nM), which was 20-fold higher than that of clozapine (Ki=30.4 nM). A-381393 exhibited highly selective binding for the dopamine D4.4 receptor (>2700-fold) when compared to D1, D2, D3 and D5 dopamine receptors. Furthermore, in comparison to clozapine and L-745870, A-381393 exhibits better receptor selectivity, showing no affinity up to 10 microM for a panel of more than 70 receptors and channels, with the exception of moderate affinity for 5-HT2A (Ki=370 nM). A-381393 potently inhibited the functional activity of agonist-induced GTP-gamma-S binding assay and 1 microM dopamine induced-Ca2+ flux in human dopamine D4.4 receptor expressing cells, but not in human dopamine D2L or D3 receptor cells. In contrast to L-745870, A-381393 did not exhibit any significant intrinsic activity in a D4.4 receptor. In vivo, A-381393 has good brain penetration after subcutaneous administration. A-381393 inhibited penile erection induced by the selective D4 agonist PD168077 in conscious rats. Thus, A-381393 is a novel selective D4 antagonist that will enhance the ability to study dopamine D4 receptors both in vitro and in vivo.
Recommended Products
  • CAS No. :31255-47-7
    Product Name:

    3-(3-Chlorophenylethyl)pyridine N-Oxide

    Cat No: R005090 View details
  • CAS No. :31255-57-9
    Product Name:

    2-Cyano-3-(3-chlorophenylethyl)pyridine

    Cat No: R005091 View details
  • CAS No. :1076199-88-6
    Product Name:

    4-Cyano-3-(3-chlorophenylethyl)pyridine

    Cat No: R005092 View details
  • CAS No. :1189880-12-3
    Product Name:

    2-(3-Chlorophenyl)-1-(3-pyridinyl-d4)-1-ethanone

    Cat No: R005093 View details